Results 41 to 50 of about 120,321 (332)

Unpacking commercial sector opposition to European smoke-free policy: lack of unity, 'fear of association' and harm reduction debates [PDF]

open access: yes, 2015
Objective: Tobacco companies have made extensive efforts to build alliances against comprehensive smoke-free legislation. This article analyses the interaction between actors who opposed the development of the European Council Recommendation on smoke ...
Amos, Amanda   +2 more
core   +1 more source

Pharmacies as potential providers of harm reduction services: A preliminary online survey [PDF]

open access: yes, 2018
Background Recreational drug use is a major cause of disease, injury, physical and mental impairment and death in developed countries such as the United Kingdom and the United States.
James, Edward   +3 more
core   +2 more sources

Understanding experts’ conflicting perspectives on tobacco harm reduction and e-cigarettes: An interpretive policy analysis

open access: yesSSM: Qualitative Research in Health, 2022
The growing use of e-cigarettes has been condemned as a significant health crisis by some and welcomed as an unprecedented opportunity to eliminate combustible tobacco by others.
Daniel Eisenkraft Klein   +2 more
doaj   +1 more source

Implications of nicotine vaping products for tobacco control in ASEAN low-income and middle-income countries: in-depth interviews with experts from the region

open access: yesBMJ Open, 2023
Objectives The use of nicotine vaping products (NVPs) has increased in low-income and middle-income countries (LMICs) in the Association of Southeast Asian Nations (ASEAN) region; however, it is uncertain what implications the presence and use of NVPs ...
Victoria White   +3 more
doaj   +1 more source

Toward pharmacy-based smoking cessation services in Nigeria: Knowledge, perception and practice of community pharmacists

open access: yesPopulation Medicine, 2021
Introduction Worldwide, tobacco smoking is one of the leading causes of avoidable deaths. In Nigeria, there is currently no clinical guidelines for tobacco dependence treatment.
Wuraola Akande-Sholabi   +1 more
doaj   +1 more source

Swedish snus and the GothiaTek® standard [PDF]

open access: yes, 2011
Some smokeless tobacco products, such as Swedish snus, are today considered to be associated with substantially fewer health hazards than cigarettes.
Lars E Rutqvist   +4 more
core   +1 more source

Industry use of evidence to influence alcohol policy: a case study of submissions to the 2008 Scottish government consultation. [PDF]

open access: yes, 2013
Jim McCambridge and colleagues analyze industry submissions to a Scottish Government consultation on whole-population approaches to alcohol ...
Hawkins, Ben   +2 more
core   +2 more sources

Intention to Switch to Smokeless Tobacco Use among South African Smokers: Results from the 2007 South African Social Attitudes Survey [PDF]

open access: yes, 2014
Background: Some smokeless tobacco products (SLT) have been shown to be associated with only a fraction of the risks of cigarettes. This study assessed South African smokers’ interest in switching to a hypothetical reduced harm SLT product.
Agaku, Israel T., Ayo-Yusuf, Olalekan A.
core   +4 more sources

A systematic review of school-based alcohol and other drug prevention programs [PDF]

open access: yes, 2015
Background: Alcohol use in adolescents constitutes a major public health concern. Europe is the heaviest drinking region of the world. Several school-based alcohol prevention programs have been developed but it is not clear whether they are really ...
Agabio R   +5 more
core   +1 more source

Heated tobacco products: another tobacco industry global strategy to slow progress in tobacco control. [PDF]

open access: yes, 2018
There has been a global decline in tobacco consumption that, if continued, will negatively impact the tobacco industry's profits. This decline led the industry to invent and market new products, including heated tobacco products (HTP).
Bialous, Stella A, Glantz, Stanton A
core  

Home - About - Disclaimer - Privacy